Author: Wang Bonnie R. Rowe Vincent L. Ham Sung Wan Han Sukgu Patel Kaushal Weaver Fred A. Woo Karen
Publisher: Southeastern Surgical Congress
ISSN: 0003-1348
Source: The American Surgeon, Vol.76, Iss.10, 2010-10, pp. : 1112-1114
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
No standard presently exists for the use of systemic heparin during angioaccess surgery to decrease the incidence of postoperative thrombotic complications. Our objective was to study the effects of intraoperatively administered heparin on 30-day patency and postoperative bleeding complications in patients undergoing autogenous arteriovenous (AV) fistula surgery. A prospective, double-blinded, randomized controlled study was performed on 48 patients undergoing AV fistula creation from April 2007 through November 2009. Of the 48 patients, 22 were randomized to the control group and received no heparin. Twenty-six were randomized to receive heparin (75 units/kg intravenously) before clamping of the artery. There was no significant difference in 30-day patency between the heparin and control groups (92%
Related content
By Lin P.H. Bush R.L. Nelson J.C. Lam R. Paladugu R. Chen C. Quinn G. Lumsden A.B.
The American Journal of Surgery, Vol. 186, Iss. 6, 2003-12 ,pp. :
By Merad Féthi Baron Gabriel Pasquet Blandine Hennet Henry Kohlmann Gérard Warlin Fred Desrousseaux Bruno Fingerhut Abe Ravaud Philippe Hay Jean-Marie
World Journal of Surgery, Vol. 36, Iss. 10, 2012-10 ,pp. :
By Kundra RK Newman S Saithna A Lewis AC Srinivasan S Srinivasan K
Annals of The Royal College of Surgeons of England, Vol. 92, Iss. 8, 2010-11 ,pp. :